Schedule 13G ownership disclosure
DAMORA THERAPEUTICS INC
Common Stock, par value $0.00001 per share · CUSIP: 36322Q206
Event date: 2025-11-12
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Point72 Asset Management, L.P.
Shares: 100,001.00 · Class: 6.3%
- Point72 Capital Advisors, Inc.
Shares: 100,001.00 · Class: 6.3%
- Steven A. Cohen
Shares: 100,001.00 · Class: 6.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-004918
- Form type
- SCHEDULE 13G
- Filer
- Galecto, Inc.
- CIK
- CIK 1800315
- Filed
- Nov 13, 2025
- Reporting period
- Nov 12, 2025
- Description
- Schedule 13G beneficial ownership